Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2026-02-24 @ 8:48 AM
Study NCT ID:
NCT03854903
Status:
COMPLETED
Last Update Posted:
2025-02-06
First Post:
2019-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor
Sponsor:
Georgetown University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY00000057
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |